Candidate for Region VII: Regional Director
1. What are your greatest contributions to ASAM and the field of addiction medicine?
Addiction Medicine is at a crossroads. Parity is the law of the land, but not always adhered to or enforced. Physician membership as Board Certified Specialists within the family of American Specialty Boards is approved, but training programs are in short supply, and there is a huge workforce shortage.
There are practices of the prescription of medications for the treatment of Addiction that do not include the psychosocial therapies that are known to result in Recovery. There is a continuing distance from the mainstream of healthcare in the most common practices of Addiction Medicine. There continue to be disconnects in the position and influence of physicians in environments for the treatment of Addiction.
There have also been abuses in the provision of Addiction healthcare that have made the integration of Addiction healthcare into the mainstream of medicine a difficult task. i.e., urine drug testing has been abused. Levels of care and lengths of stay have been recommended and provided in ways that do not resonate with the ASAM Criteria. Some physicians violate the Data 2000 Act in their lack of attention to the concurrent provision of psychosocial services.
It is my commitment to ASAM and the field of Addiction Medicine to address these looming issues, as they are able to be influenced, with a goal of complete integration of the practice of Addiction Medicine into the healthcare delivery system. It is my commitment to ASAM and to the field of Addiction Medicine to improve professionalism in each of these areas by advocacy from within ASAM for evidence based practices and consensus guidelines.
There is work to be done to assure that parity is more than a buzzword; that there is truly equal availability of resources and equal availability of expertise to address the range of presentations of addiction. There is work to be done to influence the embrace of Addiction Medicine physicians as full members of the House of Medicine. This work will require attention, focus and effort from within ASAM.
It is my commitment to do my best to enhance the position of physicians in the delivery of Addiction healthcare. It is the role of the physician to prescribe and direct the treatment of Addiction, and ASAM is the organization that can most reliably contribute to the evolution of Addiction practice in that direction.
2. How would your election benefit ASAM and the field of addiction medicine?
My privilege to serve in ASAM leadership began shortly after joining the society in 1984. I was elected to the Board of ASAM in April 1989 to replace Dr. Donald Gallant, and served on the Board as Regional Director until 1993. I n 1997, I was re-elected to the Board as Regional Director and served until April 2005. I was then elected Secretary of the Society from 2005 until 2009. I again served as a Member at Large on the Board of Directors from April 2011until April 2015. A total of 20 years and a time of great growth of the society.
I n the years following initial board membership I have served on a number of ASAM committees. I was a member of the Review Course Committee chaired by Dr. Anne Gellar and Co-Director of the Review Course in Atlanta in 1990. Inspired by the rewards of volunteerism, I have served as chair and then member of the Membership Committee, and I have done my best to contribute to the direction of the society and to the publications of the society as a member of the Public Policy Committee. I have most significantly contributed to those publications in the development of the Public Policy Statement on the Treatment of Addiction. I serve on the Legislative Advocacy Committee and I am a member of the Payer Relations Committee. I have been appointed as Board level liaison to the National Association of Addiction Treatment Providers.
The most memorable volunteer effort in ASAM was the opportunity to chair the Parity Action Group (which then became the Legislative Advocacy Committee). For my work with the Parity Action Group, I was honored with the ASAM Award, an annual award for outstanding contributions to the growth and vitality of our society: “For thoughtful leadership in the field and for the deep understanding of the art and sciences of Addiction Medicine. That honor was bestowed on April 17th, 2010.
However, I believe that my most significant contribution to ASAM has also been a gift of my membership in ASAM. Because of my exposure to my fellow members and to the educational presentations of ASAM, and inspired by the practices and accomplishments of my colleagues, and influenced by my former experience as a primary care physician, I have been able to develop a physician led Recovery Oriented System of Care in Metairie, LA. My leadership in this organization has been a role model for others, and stands as one example of the future of physician practice in Addiction Medicine. I hope to continue as a role model and advocate for physician leadership and integration into the multidisciplinary treatment of addiction.
Ken Roy, MD is founder and medical director of the Dual Diagnosis unit at River Oaks Hospital in Harahan, LA and president and medical director of Bio behavioral Medicine Company, LLC in Metairie, LA., an addiction focused medical practice and Addiction Recovery Resources, Inc., an outpatient and residential treatment program for addiction, also in Metairie. Dr Roy has had a successful addiction and psychiatric private practice for over 25 years.
Dr. Roy received his medical degree from Tulane University School of Medicine in New Orleans. He completed his internship at the Charity Hospital of New Orleans and a residency in psychiatry at the Tulane University School of Medicine. Dr. Roy is a Distinguished Life Fellow of the American Psychiatric Association, a Distinguished Fellow of the American Society of Addiction Medicine and is certified by the American Board of Psychiatry and Neurology and the American Board of Addiction Medicine. He also is a member of the American Academy of Addiction Psychiatry and the American Medical Association.